ReCap Total Hip Resurfacing Prospective Data Collection

This study has been terminated.
Biomet U.K. Ltd.
Information provided by (Responsible Party):
Biomet, Inc. Identifier:
First received: September 23, 2008
Last updated: May 4, 2012
Last verified: May 2012
Prospective data collection on survivorship of ReCap Total Hip Resurfacing

Condition Intervention
Device: ReCap Total Hip Resurfacing

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: ReCap Total Hip Resurfacing Prospective Data Collection

Further study details as provided by Biomet, Inc.:

Primary Outcome Measures:
  • survival rate [ Time Frame: 10 yr ] [ Designated as safety issue: Yes ]

Enrollment: 82
Study Start Date: March 2005
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Hip Resurfacing Device: ReCap Total Hip Resurfacing
ReCap Total Hip Resurfacing
Other Name: RECAP

Detailed Description:
Detailed protocol not available

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients suitable for Total Hip Resurfacing

Inclusion Criteria:

  • Clinical diagnosis of hip joint arthritis

Exclusion criteria:

- less than 18 years of age

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00758472

United Kingdom
Southmead Hospital
Bristol, United Kingdom
Robert Jones & Agnes Hunt Orthopaedic & District Hospital NHS Trust
Oswestry, United Kingdom
Sponsors and Collaborators
Biomet, Inc.
Biomet U.K. Ltd.
Principal Investigator: Evert Smith, MD North Bristol NHS Trust
  More Information

Responsible Party: Biomet, Inc. Identifier: NCT00758472     History of Changes
Other Study ID Numbers: BMET UK 08 
Study First Received: September 23, 2008
Last Updated: May 4, 2012
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency processed this record on April 27, 2016